Objective: To characterize the vessel wall imaging findings and enhancement patterns in the middle cerebral artery of patients with presumed atherosclerotic disease and recent infarction in the territory of the affected artery.
R
ECENT STUDIES [1] [2] [3] [4] [5] HAVE SHOWN that 3-T high-resolution magnetic resonance imaging (HR-MRI) can be used to study the wall of intracranial arteries. Early experience with wall imaging suggests that intracranial atherosclerosis is associated with eccentric, usually irregular wall thickening similar to extracranial atherosclerosis. [1] [2] [3] It remains unknown whether HR-MRI can discriminate between active and stable plaques in patients with presumed intracranial atherosclerotic disease. Therefore, the aim of this case series was to further describe the wall imaging findings of the middle cerebral arteries (MCAs) of patients with presumed atherosclerotic intracranial disease who had developed a recent ischemic stroke in the territory of their stenosis.
METHODS

PATIENTS
We reviewed the medical records of patients admitted to our institution (Toronto Western Hospital, a designated stroke center) who underwent 3-T MRI vessel wall imaging. These files contained data on 107 patients from February 1, 2006, through January 5, 2010, including 37 previously reported patients. 1 Inclusion criteria for the present study were (1) 2 or more risk factors for atherosclerotic disease; (2) MCA stenosis shown on computed tomography, magnetic resonance, or conventional angiography; (3) cerebral infarction in the territory of the affected MCA; and (4) use of 3-T contrast-enhanced HR-MRI. Exclusion criteria were (1) complete MCA occlusion; (2) vasculitis; (3) Moya-Moya disease; (4) poor image quality secondary to motion artifacts; and (5) previously reported in the literature. We scored the following stroke risk factors in each patient: age, sex, hypertension, diabetes mellitus, dyslipidemia (defined as current use of lipid-lowering drugs or low-density lipoprotein cholesterol Ͼ96.5 mg/dL [to convert to millimoles per liter, multiply by 0.0259]), coronary artery disease, previous stroke or transient ischemic attack, (paroxysmal) atrial fibrillation or flutter, and cigarette smoking. Results of hypercoagulable and vasculitis workup were retrieved from electronic patient records. Information on the presence of atherosclerosis in the carotid and vertebral arteries was retrieved from magnetic resonance or computed tomography angiographic findings.
Approval for retrospective review of medical record and imaging data of all patients who underwent scanning with the 3-T vessel wall imaging protocol was granted by the Toronto Western Hospital Research Ethics Board.
IMAGING PROTOCOL AND ANALYSIS
Information on at least 1 method of conventional luminal imaging (magnetic resonance, computed tomography, or digital subtraction angiography) was available for all patients to confirm the presence of an MCA stenosis. Scanning was performed with a 3-T MRI system (HDX platform; GE Healthcare, Milwaukee, Wisconsin) using an 8-channel head coil. All sequences applied were standard, approved, vendorsupplied pulse sequences. No experimental sequences were applied. The vessel wall imaging protocol consisted of a minimum of 7 sequences on 3-T MRI: (1) axial and coronal T2-weighted images; (2) precontrast axial and coronal T1 fluid-attenuated inversion recovery images; (3) postcontrast axial and coronal T1 fluid-attenuated inversion recovery images; and (4) time-of-flight magnetic resonance angiography. Sagittal images were added if needed. All sequences were monitored for appropriate targeting of the vessel of interest and to ensure that the orientation was successful to capture the affected artery at the site of stenosis in at least 2 planes of section. Imaging analysis was performed using a radiology information system picture archiving and communication system. Vessel wall images were scored by visual inspection for location of MCA stenosis, pattern of stenosis (eccentricity), and enhancement of the vessel wall. Eccentric enhancement was defined as either clearly limited to 1 side of the vessel wall or, when circumferential enhancement was noted, the thinnest part of the wall enhancement was estimated to be less than 50% of the thickest enhancing wall component. The presence of enhancement was assessed qualitatively by an experienced observer (D.J.M.) through comparison of the T1 images before and after gadolinium administration. Intracerebral arteries other than the affected MCA were scored for the presence of stenosis.
RESULTS
We identified 8 previously unreported patients ( Table 1,  Table 2 , and Figure 1 ). Mean age was 67 years (range, 50-76 years), and 3 patients were male. Median time of vessel wall imaging after the index event was 5.5 days (range, 1 day to 5 months). Nine MCA stenoses were identified (1 patient had bilateral stenoses). In 6 patients, the MCA stenosis involved the M1 segment (for example, Figure 2 ) in combination with cerebral infarction within this territory. All M1 stenoses had eccentric morphology. Two patients had an M2 branch stenosis without involvement of the M1 segment: 1 patient had a distal M2 stenosis with inconclusive eccentricity and possibly a filling defect, and 1 patient had bilateral M2 stenoses. In the latter patient, the symptomatic MCA had a proximal eccentric M2 stenosis. All patients with infarcts within the MCA territory who underwent scanning within 5 months of the index event had enhancement of their stenotic plaques. The patient who had bilateral MCA stenoses had enhancement only of the plaque on the side of the recent infarction and not on the asymptomatic contralateral side. Three patients had atherosclerotic changes in other intracranial arteries without enhancement, and 3 patients had atherosclerotic changes in the extracranial cervical arteries.
COMMENT
Our data suggest that patients with presumed intracranial atherosclerosis of the MCAs have eccentric plaques that enhance after the administration of contrast medium when imaging is performed within weeks to months of a cerebral infarct within the arterial territory. We speculate that plaque enhancement may represent an unstable plaque and unstable plaques may be more likely to lead to cerebral infarction.
In our case series, the patient who underwent scanning 5 months after stroke still had enhancement of the affected MCA. In previous case series, 1 enhancement was not shown when scans were performed more than 2 months after stroke. It could be that the patient with plaque enhancement after 5 months had a plaque that was still unstable or again unstable. Fortunately, this patient did not have recurrence of stroke symptoms at the time of the scan. Studies are needed to determine whether plaque enhancement is associated with an increased risk of future stroke.
One important limitation of the study is that histopathologic confirmation of plaque instability was not possible because all patients survived their stroke. However, a large body of indirect evidence supports the hypothesis that eccentric gadolinium enhancement represents unstable atherosclerotic plaques. First, our results are in line with results of earlier studies 6 that investigated plaque instability shown on HR-MRI in patients with extracranial atherosclerotic disease. Carotid endarterectomy studies 7, 8 suggest that a large lipid core with a thin overlying fibrous cap are features of plaque vulnerability. Rupture of the thin fibrous cap exposes the thrombogenic lipid core of the atheroma to flowing blood, with subsequent thrombus formation and ischemic stroke. 8, 9 A histologic correlation study 10 in patients with a carotid artery stenosis showed that gadolinium enhancement corresponded to fibrocellular tissue, including the fibrous cap. Eccentric vessel wall enhancement has been shown on histopathologic testing to be related to unstable atherosclerotic plaques in patients with femoral and abdominal aortic artery plaques.
11 Autopsy studies 12,13 of intracranial atherosclerotic disease have shown that MCA atherosclerosis is associated with an ischemic stroke in the corresponding territory and that the degree of MCA stenosis; percentage of the plaques containing more than 40% lipid area; and prevalence of intraplaque hemorrhage, neovasculature, and thrombus are higher in plaque associated with infarction. 14 Other common causes of intracranial vessel wall abnormalities were unlikely in our group of patients. Dissections typically show a false lumen and bright wall components on non−contrast-enhanced T1 MRI imaging as a result of methemoglobin representing intramural hematoma. 1 This was not observed in our patients. Furthermore, vasculitis was an unlikely cause, since patients with vasculitis typically show circumferential concentric wall thickening with diffuse gadolinium enhancement of the inflamed wall, 1, 15 and vasculitis was an exclusion criterion for this case series.
In conclusion, our data suggest that an eccentric MCA stenosis is related to atherosclerotic disease and that enhancement may represent unstable plaque. These findings are similar to those described in patients with extracranial atherosclerotic plaques, where the presence of 
